Navigation Links
Little evidence to support TB interventions in real-world, low-resource settings
Date:12/18/2012

There is little evidence from real world situations in low-and-middle income countries to support the effectiveness and financial value of five interventions* recommended by the World Health Organization (WHO) to control tuberculosis, which may be a reason why these interventions have not been implemented in many countries, according to a study by international experts published in this week's PLOS Medicine.

Over the past few years, WHO has recommended that countries implement several interventions to help control the spread of tuberculosis through measures to improve prevention, diagnosis, and treatment. The authors led by Frank Cobelens from the Amsterdam Institute of Global Health and Development in the Netherlands reviewed 208 appropriate studies to investigate the evidence for the effectiveness of each of these interventions and also for additional information on the setting and conditions of implemented interventions, which might be useful to other countries.

The authors found that there were very few real-world studies reporting on the effectiveness of interventions in program settings (rather than in optimal conditions under research settings). Few studies evaluated the methods used to implement the intervention or addressed delivery and operational issues (such as adherence to treatment) and there were few economic evaluations of the recommended interventions.

The authors say: "There are substantial gaps in published evidence for scale-up for five WHO-recommended TB interventions settings at country level, which for many countries possibly precludes program-wide implementation of these interventions."

They continue: "This lack of ''evidence for scale-up'' may be an important cause of the shortfall in implementation of these interventions in many countries."

The authors add: "There is a strong need for rigorous operational research studies to be carried out in programmatic settings to inform on best of existing and new interventions in TB control."


'/>"/>
Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
Public Library of Science
Source:Eurekalert

Related medicine news :

1. In children born with severe heart defect, surgical management has little effect on neuro outcomes
2. U.S. Spends Too Little on Public Health Initiatives: Report
3. Botox Offers Little Relief for Migraine, Study Finds
4. A Little More Education, a Little Longer Life?
5. OSHAs Safety Tests Protect Workers at Little Cost: Study
6. Too much vitamin D can be as unhealthy as too little
7. New federal disclosure law may have little impact on drugs prescribed
8. Kids Born Even a Little Early Have Lower School Scores: Study
9. Milk Thistle of Little Help Against Hepatitis C: Study
10. Little evidence supports autism treatment options in adolescents
11. Little Evidence on Value of Treatments for Autism: Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology: